CD40LG and infection: An increase in IgM+ cells occurred rapidly in response to all treatments, with percentages of these cells fluctuating over time in response to adjuvant or vaccine, suggesting B-cell (and presumably IgM-bearing monocyte) movement to the site of infection or immune response.